On January 2, 2026, Evolent Health, Inc. (NYSE: EVH), a leader in providing healthcare solutions aimed at improving outcomes for patients with complex conditions, made headlines by announcing a significant inducement award for its newly appointed Chief Financial Officer, Mr. Mario Ramos. This strategic move is part of the company's ongoing commitment to enhancing its leadership team as it strives to deliver more effective and affordable healthcare solutions.

2. Details of the Inducement Award

The Compensation Committee of Evolent's Board of Directors approved the granting of a one-time time-based restricted stock unit award covering 587,500 shares of Evolent Class A common stock, valued at approximately $2,350,000. This Inducement Award is designed to incentivize Mr. Ramos as he transitions into his new role, emphasizing the company's commitment to attracting top talent from outside its existing workforce.

Under the terms of the Inducement Award, the stock units will vest in a staggered manner: 34% will vest on the first anniversary of the grant date, followed by 33% on the second anniversary, and the remaining 33% on the third anniversary. However, the vesting is contingent upon Mr. Ramos's continued employment with Evolent through the applicable vesting dates. This structure not only aligns Mr. Ramos's financial interests with those of the company but also encourages long-term commitment to its goals.

3. Compliance with NYSE Regulations

This award comes in accordance with the New York Stock Exchange Listing Rule 303A.08, which allows for such inducement awards when the recipient is neither a former employee returning after a bona fide period of non-employment nor an existing employee. By adhering to these regulations, Evolent demonstrates its commitment to governance standards while reinforcing its capacity to attract high-caliber professionals in the healthcare sector.

4. Evolent's Commitment to Healthcare Innovation

Evolent Health is renowned for its innovative approach to healthcare, focusing on simplifying access to care and improving health outcomes for individuals with complex conditions. The company serves a diverse national base of payers and providers, and its recognition as a top workplace in healthcare underscores its commitment to employee satisfaction and corporate culture.

As Evolent continues to expand its footprint in the healthcare industry, the addition of Mr. Ramos to its leadership team is seen as a strategic move aimed at fostering growth and enhancing operational efficiency. His financial acumen is expected to contribute significantly to the company's objectives of delivering effective, affordable healthcare solutions.

5. Conclusion

The announcement of the inducement award for Mr. Mario Ramos marks a pivotal point for Evolent Health as it ushers in a new era of leadership. As the company continues to innovate within the healthcare landscape, it remains poised to make significant strides in improving the lives of those it serves. With strategic initiatives like this one, Evolent is well-positioned to maintain its status as a leader in the industry.

For additional information about Evolent Health and its commitment to transforming healthcare delivery, visit evolent.com.

Original press release